| View |
|
DRHR-2076
|
Hydroquinone + Tretinoin
|
Hydrance Hydrating and Brightening Toner
|
50 mg/5 mg (0.05%/0.005% w/w)
|
Topical Solution
|
-
|
Cosmolab Philippines, Co.
|
Philippines
|
-
|
04 November 2021
|
04 November 2026
|
| View |
|
DRHR-2077
|
Hydroquinone + Tretinoin
|
Hydrance Hydrating and Brightening Toner
|
30 mg/500 mcg (0.003%/0.050% w/w) per 100 g
|
Cream
|
-
|
Cosmolab Philippines, Co.
|
Philippines
|
-
|
04 November 2021
|
04 November 2026
|
| View |
|
DRP-3246-03
|
Dicycloverine (as Hydrochloride)
|
Cloverine
|
10mg/ 5mL
|
Syrup
|
-
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
-
|
25 October 2021
|
22 September 2026
|
| View |
|
DRP-4522-03
|
Dicycloverine Hydrochloride
|
Cloverine
|
10 mg
|
Tablet
|
Anticholinergic
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
Automatic Renewal
|
12 July 2023
|
12 July 2028
|
| View |
|
DRP-8300-06
|
Rosuvastatin (as calcium)
|
Fadztat
|
20 mg
|
Film-Coated Tablet
|
Anti-hypercholesterolemia / Anti-dyslipidemia
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Renewal
|
15 March 2024
|
07 August 2029
|
| View |
|
DRP-4070-11
|
Fenofibrate
|
Fenofadz
|
200 mg
|
Capsule
|
Lipid Modifying Agent (Fibrate)
|
XL Laboratories Pvt. Ltd.
|
India
|
Automatic Renewal
|
07 April 2022
|
19 October 2027
|
| View |
|
DRP-8442-03
|
Nicardipine Hydrochloride
|
Icard IV
|
1 mg/mL (10mg/10mL)
|
Solution For Injection (IV)
|
Calcium Channel Blocker
|
Aju Pharma Co., Ltd.
|
Korea
|
Automatic Renewal
|
29 October 2022
|
24 November 2027
|
| View |
|
DRP-993-04
|
Amlodipine (As Besilate)
|
None
|
10 mg
|
Tablet
|
Calcium Channel Blocker
(Dihydropyridine Derivative)
|
Plethico Pharmaceuticals Ltd.
|
India
|
Automatic Renewal
|
22 November 2022
|
30 January 2028
|
| View |
|
DRP-996-04
|
Losartan Potassium
|
None
|
50 mg
|
Film Coated Tablet
|
Angiotensin-2-Receptor Blocker (ARB)
|
Plethico Pharmaceuticals Ltd.
|
India
|
Renewal
|
29 March 2022
|
12 November 2027
|
| View |
|
DRP-2223-04
|
Ampicillin (As Sodium)
|
Gopen 250
|
250 mg/vial
|
Powder For Injection (IV/IM)
|
Antibacterial (Penicillin)
|
Umedica Laboratories Pvt. Ltd.
|
India
|
Initial
|
25 October 2021
|
03 June 2025
|
| View |
|
DRP-9072-01
|
Cefoxitin (As Sodium)
|
Deceftin
|
1 g
|
Powder for Injection (IM/IV)
|
-
|
Swiss Parenterals Ltd.
|
India
|
-
|
03 November 2021
|
12 August 2025
|
| View |
|
DRP-2640-03
|
Clindamycin (As Hydrochloride)
|
Klindex
|
300 mg
|
Capsule
|
Antibacterial (Lincosamide)
|
Amherst Laboratories, Inc.
|
Philippines
|
Renewal
|
28 April 2022
|
25 May 2027
|
| View |
|
DRP-6143-01
|
Felodipine
|
Felostar
|
10 mg
|
Extended-Release Tablet
|
Calcium Channel Blocker
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Renewal
|
08 July 2024
|
11 May 2030
|
| View |
|
DRP-2222-03
|
Cefepime (as Hydrochloride)
|
None
|
1 g
|
Powder for Injection (IM/IV)
|
Antibacterial (Cephalosporin)
|
Zazen Pharma Pvt. Ltd.
|
India
|
CLIDP
|
27 October 2021
|
02 June 2025
|
| View |
|
DRP-5025-42
|
Omeprazole (As Sodium)
|
Fadzole
|
40 mg
|
Powder For Injection (IV)
|
Proton Pump (H+K+ATPase) Inhibitor
|
Shreechem Pharmaceuticals Pvt. Ltd.
|
India
|
Automatic Renewal
|
22 July 2023
|
27 December 2028
|
| View |
|
DRP-4164-29
|
Cefuroxime (As Axetil)
|
Oxifadz
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Cephalosporin)
|
Brawn Laboratories Limited
|
India
|
Automatic Renewal
|
07 April 2022
|
27 December 2027
|
| View |
|
DRP-8620-02
|
Ketoanalogues + Essential Amino Acids
|
Metaketo
|
Calcium-4-methyl-2-oxovalerate (a-ketoanalogue of leucine, Calcium salt) Calcium-3-methyl-2-oxobutyrate (a -ketoanalogue of valine, Calcium salt) Calcium-2-oxo-3-phenylpropionate (a-ketoanalogue of phenylalanine, Calcium salt) Calcium 3-methyl-2-oxovaleratela -ketoanalogue of isoleucine, Calcium salt) Calcium-DL-2-hydroxy-4-(methylthio)-butyrate (a-hydroxyanalogue of methionine, calcium salt) L-Lysine Acetate L-Threonine L-Histidine L-Tyrosine L-Tryptophan
68 mg
67 mg 59 mg
105 mg
53 mg 38 mg 30 mg 23 mg
|
Film-Coated Tablet
|
-
|
Hebei Tiancheng Pharmaceutical Co., Ltd.
|
China
|
-
|
27 October 2021
|
06 April 2025
|
| View |
|
DRP-9070-01
|
Amlodipine (as Besilate) + Valsartan
|
None
|
500 mg
|
Powder for Injection (I.V. Infusion)
|
-
|
ACS Dobfar S.P.A
|
Italy
|
-
|
27 October 2021
|
11 August 2025
|
| View |
|
DRP-9068-01
|
Amlodipine (as Besilate) + Valsartan
|
None
|
1 g
|
Powder for Injection (I.V. Infusion)
|
-
|
ACS Dobfar S.P.A
|
Italy
|
-
|
27 October 2021
|
11 August 2025
|
| View |
|
DRP-3995-27
|
Cefuroxime (As Sodium)
|
Oxifadz
|
750 mg
|
Powder For Injection (Im/Iv)
|
ANTIBACTERIAL (CEPHALOSPORIN)
|
Shreechem Pharmaceuticals Pvt. Ltd.
|
India
|
-
|
14 March 2022
|
28 September 2027
|